HCPCS Level II
J9021
Injection, asparaginase, recombinant, (rylaze), 0.1 mg
Codes near J9021
These sit next to J9021 in the CMS Level II file. All J codes
- J9011Injection, datopotamab deruxtecan-dlnk, 1 mg
- J9015Injection, aldesleukin, per single use vial
- J9017Injection, arsenic trioxide, 1 mg
- J9019Injection, asparaginase (erwinaze), 1, 000 iu
- J9020Injection, asparaginase, not otherwise specified, 10, 000 units
- J9022Injection, atezolizumab, 10 mg
- J9023Injection, avelumab, 10 mg
- J9024Injection, atezolizumab, 5 mg and hyaluronidase-tqjs
- J9025Injection, azacitidine, 1 mg
- J9026Injection, tarlatamab-dlle, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 68727-0900-03 | Rylaze | Jazz Pharmaceuticals, Inc. | 300 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.